参考文献/References:
[1]赵龙,关广聚.糖尿病肾病发病机制研究进展[J].中华肾脏病杂志,2013,29(7):554-558.
[2]陈灏珠,钟南山,陆再英.内科学[M].第8版.北京:人民卫生出版社,2013:738.
[3]韩颖,李素芬,刘艳.血清胱抑素C与糖尿病肾病[J].国际内分泌代谢杂志,2014,34(3):207-210.
[4]张翠平,陈璟.老年2型糖尿病肾病患者血清胱抑素C、脂蛋白(α)与尿微量清蛋白/肌酐的相关性研究[J].国际检验医学杂志,2017,38(8):1029-1031.
[5]王慧平,阿孜亚,伊雪.血清脂蛋白(a)与2型糖尿病及其微血管并发症的相关性分析[J].中国卫生检验杂志,2014,24(12):1740-1741,1747.
[6]Gallagher H,Suckling RJ.Diabetic nephropathy:where are weon the journey from pathophysiology to treatment[J].Diabetes Obesity&Metabolism,2016,18(7):641-647.
[7]Liu ZH.Nephrology in China[J].Nat Rev Nephrol,2013,9(9):523-528.
[8]吴震.肾内科糖尿病肾病患者的临床特点及诊治分析[J].中国实用医药,2018(4):28-29.
[9]赵宪文.糖尿病肾病患者胱抑素C与肌酐尿素氮测定比较[J].医疗与保健,2014(11):51.
[10]崔珺.胱抑素C临床检验及在肾脏疾病应用中的分析[J].中国继续医学教育,2016,8(21):32-33.
[11]Floresblanco PJ,Manzanofernández S,Pérezcalvo JI,et al.Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure[J].Clinical Cardiology,2015,38(2):106-113.
[12]贾利敏,糖尿病肾病患者脂蛋白α变化的研究[J].现代中西医结合杂志,2014,23(7):769-771.
[13]Liu C,Xu MX,He YM,et al.Lipoprotein(a)is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls[J].Acta Diabetologica,2017,54(5):443-453.
[14]林红军,吴风,王丽娜.老年糖尿病患者血清脂蛋白a和胱抑素C与微血管并发症的关系[J].中国老年学杂志,2015,35(4):908-909.
[15]梁惠霞.2型糖尿病肾病患者血尿酸与血脂水平的检测及其临床意义[J].国际检验医学杂志,2013,34(21):2916-2917.
[16]韩晓芳,张新秀,刘克梅,等.2型糖尿病患者血尿酸与糖尿病肾病的相关性[J].安徽医学,2016,37(7):865-868.
相似文献/References:
[1]李 艳.胱抑素C临床检验及对诊断肾脏疾病的临床价值[J].医学信息,2018,31(04):42.[doi:10.3969/j.issn.1006-1959.2018.04.014]
LI Yan.Clinical Test of Cystatin C and its Clinical Value in the Diagnosis of Renal Diseases[J].Journal of Medical Information,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.04.014]
[2]熊武芳,杨 娜,肖光军,等.同一厂家两种胱抑素C检测试剂盒的性能验证及其
检测结果的一致性[J].医学信息,2018,31(15):55.[doi:10.3969/j.issn.1006-1959.2018.15.018]
XIONG Wu-fang,YANG Na,XIAO Guang-jun,et al.Performance Verification of Two Cystatin C Test Kits and Consistency of Test Results from the Same Manufacturer[J].Journal of Medical Information,2018,31(14):55.[doi:10.3969/j.issn.1006-1959.2018.15.018]
[3]叶 亮,李运泽,彭继承,等.血清Cys-C、α1-MG联合检测在早期肝肾综合征诊断中的意义[J].医学信息,2022,35(16):67.[doi:10.3969/j.issn.1006-1959.2022.16.014]
YE Liang,LI Yun-ze,PENG Ji-cheng,et al.Significance of Combined Detection of Serum Cys-C and α1-MG in Diagnosis of Early Hepatorenal Syndrome[J].Journal of Medical Information,2022,35(14):67.[doi:10.3969/j.issn.1006-1959.2022.16.014]
[4]韩佳妮.参芪地黄汤治疗早期糖尿病肾病的疗效[J].医学信息,2019,32(22):139.[doi:10.3969/j.issn.1006-1959.2019.22.047]
HAN Jia-ni.Effect of Shenqi Dihuang Decoction in Treating Early Diabetic Nephropathy[J].Journal of Medical Information,2019,32(14):139.[doi:10.3969/j.issn.1006-1959.2019.22.047]
[5]伊学军,翟建新.胱抑素C检测及其在肾脏相关疾病中的应用[J].医学信息,2020,33(04):55.[doi:10.3969/j.issn.1006-1959.2020.04.017]
YI Xue-jun,ZHAI Jian-xin.Cystatin C Detection and its Application in Kidney-related Diseases[J].Journal of Medical Information,2020,33(14):55.[doi:10.3969/j.issn.1006-1959.2020.04.017]
[6]段宗宝,肖三法,罗惠群.环磷酰胺联合氢氯噻嗪治疗2型糖尿病肾病的临床研究[J].医学信息,2021,34(23):159.[doi:10.3969/j.issn.1006-1959.2021.23.048]
DUAN Zong-bao,XIAO San-fa,LUO Hui-qun.Clinical Study of Cyclophosphamide Combined with Hydrochlorothiazide in the Treatment of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2021,34(14):159.[doi:10.3969/j.issn.1006-1959.2021.23.048]
[7]马 燕,王晓忠,延国威,等.乙肝肝硬化低血钠症患者血清钠、肌酐以及胱抑素C与肾功能损害程度的关系[J].医学信息,2020,33(19):55.[doi:10.3969/j.issn.1006-1959.2020.19.017]
MA Yan,WANG Xiao-zhong,YAN Guo-wei,et al.The Relationship Between Serum Sodium,Creatinine,Cystatin C and the Degree of Renal Damage in Patients with Hepatitis B Liver Cirrhosis and Hyponatremia[J].Journal of Medical Information,2020,33(14):55.[doi:10.3969/j.issn.1006-1959.2020.19.017]
[8]舒霁坤,沈学耕.慢性心力衰竭患者炎症细胞因子水平与心室重构的相关性分析[J].医学信息,2022,35(02):100.[doi:10.3969/j.issn.1006-1959.2022.02.024]
SHU Ji-kun,SHEN Xue-geng.Correlation Between Inflammatory Cytokines and Ventricular Remodelingin Patients with Chronic Heart Failure[J].Journal of Medical Information,2022,35(14):100.[doi:10.3969/j.issn.1006-1959.2022.02.024]
[9]张慧敏,夏海龙,刘 北,等.胱抑素C、铁蛋白与骨髓瘤骨病病情严重程度及预后的关系[J].医学信息,2024,37(03):89.[doi:10.3969/j.issn.1006-1959.2024.03.017]
ZHANG Hui-min,XIA Hai-long,LIU Bei,et al.Relationship Between Cystatin C, Ferritin and the Severity, Prognosis of Multiple Myeloma Bone Disease[J].Journal of Medical Information,2024,37(14):89.[doi:10.3969/j.issn.1006-1959.2024.03.017]